Guardian Pharmacy Services (NYSE:GRDN) Now Covered by Raymond James

Research analysts at Raymond James initiated coverage on shares of Guardian Pharmacy Services (NYSE:GRDN) in a report released on Monday, Marketbeat reports. The brokerage set an “outperform” rating and a $21.00 price target on the stock. Raymond James’ target price would suggest a potential upside of 16.60% from the stock’s previous close.

Separately, Truist Financial initiated coverage on shares of Guardian Pharmacy Services in a research note on Monday. They set a “buy” rating and a $22.00 price objective on the stock.

Guardian Pharmacy Services Stock Performance

GRDN stock opened at $18.01 on Monday. Guardian Pharmacy Services has a 52-week low of $14.16 and a 52-week high of $20.10.

Insider Transactions at Guardian Pharmacy Services

In other news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the acquisition, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Hedge Funds Weigh In On Guardian Pharmacy Services

A hedge fund recently bought a new stake in Guardian Pharmacy Services stock. Seven Grand Managers LLC purchased a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 149,700 shares of the company’s stock, valued at approximately $2,515,000. Seven Grand Managers LLC owned 0.24% of Guardian Pharmacy Services as of its most recent filing with the Securities and Exchange Commission.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.